# Cure EB

> Cure EB is a VC fund in London backing Biotechnology and Medical. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 3
- Last investment: Jul 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/cure-eb
- Website: https://cure-eb.org

Cure EB is a nonprofit organization dedicated to funding research and accelerating the development of effective treatments and ultimately a cure for Epidermolysis Bullosa (EB), a rare and debilitating genetic skin disorder. The organization focuses on raising awareness, supporting scientific research, and collaborating with leading researchers,biotech companies, and healthcare professionals worldwide to advance promising therapies for EB.

## Contacts

5 contacts available for Cure EB. Shizune tracks 2 team members at Cure EB. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cure-eb?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Medical | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Funding Round | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| James Collins | Co-Founder and Trustee | 0 | https://shizune.co/investors/profile/james-collins-96a6 |
| Sharmila Nikapota | Co-Founder and Trustee | 1 | https://shizune.co/investors/profile/sharmila-nikapota |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Healome Therapeutics | Healome Therapeutics | $2.7M | Seed | Jul 07, 2026 |  |
| Eliksa Therapeutics | Eliksa Therapeutics is a biotechnology company that develops regenerative medicine. |  |  | Oct 29, 2025 |  |
| Nova Anchora | Nova Anchora, a biopharmaceutical startup, is developing a corrected protein therapy for DEB, a severe uncommon skin disease. |  | Venture - Series Unknown | Apr 29, 2025 |  |

3 of 3 investments shown.

## Co-investors
- [DEBRA Research](https://shizune.co/investors/profile/debra-research) — VC Fund, 3 deals together
- [EB Medical Research Foundation](https://shizune.co/investors/profile/eb-medical-research-foundation) — VC Fund, 2 deals together
- [EB Research Partnership](https://shizune.co/investors/profile/eb-research-partnership) — VC Fund, 2 deals together
- [ABE](https://shizune.co/investors/profile/abe-2f68) — VC Fund, 1 deal together
- [Empirical Ventures](https://shizune.co/investors/profile/empirical-ventures) — VC Fund, 1 deal together
- [Oshen](https://shizune.co/investors/profile/oshen-61bf) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Cure EB invest in?

Cure EB invests primarily in Biotechnology and Medical startups, most often at Seed and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Cure EB?

Public channels for Cure EB include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Cure EB?

The team at Cure EB includes James Collins (Co-Founder and Trustee) and Sharmila Nikapota (Co-Founder and Trustee). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co